Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 2851 AL 2865

Protein Quality Control by Molecular Chaperones in Neurodegeneration

Ciechanover A, Kwon YT.

Front Neurosci. 2017 Apr 6;11:185. doi: 10.3389/fnins.2017.00185. eCollection 2017.

Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature

Tarolli CG, Chesire AM, Biglan KM.

Tremor Other Hyperkinet Mov (N Y). 2017 Apr 11;7:454. doi: 10.7916/D88057C7. eCollection 2017.

"Diabetic striatopathy" and ketoacidosis: Report of two cases and review of literature

Das L, Pal R, Dutta P, Bhansali A.

Diabetes Res Clin Pract. 2017 Jun;128:1-5. doi: 10.1016/j.diabres.2017.03.008. Epub 2017 Apr 9.

Wilson disease: neurologic features

Członkowska A, Litwin T, Chabik G.

Handb Clin Neurol. 2017;142:101-119. doi: 10.1016/B978-0-444-63625-6.00010-0.

Symptomatic treatment of neurologic symptoms in Wilson disease

Litwin T, Dušek P, Członkowska A.

Handb Clin Neurol. 2017;142:211-223. doi: 10.1016/B978-0-444-63625-6.00018-5.

A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease

Verny C, Bachoud-Lévi AC, Durr A, Goizet C, Azulay JP, Simonin C, Tranchant C, Calvas F, Krystkowiak P, Charles P, Youssov K, Scherer C, Prundean A, Olivier A, Reynier P, Saudou F, Maison P, Allain P, von Studnitz E, Bonneau D; CYST-HD Study Group.

Mov Disord. 2017 Jun;32(6):932-936. doi: 10.1002/mds.27010. Epub 2017 Apr 24.

Neurotrophin receptors in the pathogenesis, diagnosis and therapy of neurodegenerative diseases

Meldolesi J.

Pharmacol Res. 2017 Jul;121:129-137. doi: 10.1016/j.phrs.2017.04.024. Epub 2017 Apr 21.

SIRT3 and mitochondrial metabolism in neurodegenerative diseases

Salvatori I, Valle C, Ferri A, Carrì MT.

Neurochem Int. 2017 Oct;109:184-192. doi: 10.1016/j.neuint.2017.04.012. Epub 2017 Apr 25.

Head drops: electromyography may give the way

Antelmi E, Plazzi G.

Sleep Med. 2017 May;33:68-69. doi: 10.1016/j.sleep.2016.11.027. Epub 2017 Jan 27.

Feasibility of computerized working memory training in individuals with Huntington disease

Sadeghi M, Barlow-Krelina E, Gibbons C, Shaikh KT, Fung WLA, Meschino WS, Till C.

PLoS One. 2017 Apr 28;12(4):e0176429. doi: 10.1371/journal.pone.0176429. eCollection 2017.

Neurodegeneration and the Cerebellum

Samson M, Claassen DO.

Neurodegener Dis. 2017;17(4-5):155-165. doi: 10.1159/000460818. Epub 2017 May 3.

Cataplexy and Its Mimics: Clinical Recognition and Management

Pillen S, Pizza F, Dhondt K, Scammell TE, Overeem S.

Curr Treat Options Neurol. 2017 Jun;19(6):23. doi: 10.1007/s11940-017-0459-0.

Melatonin receptors: distribution in mammalian brain and their respective putative functions

Ng KY, Leong MK, Liang H, Paxinos G.

Brain Struct Funct. 2017 Sep;222(7):2921-2939. doi: 10.1007/s00429-017-1439-6. Epub 2017 May 6.

Use of zuclopenthixol in the treatment of aggression in Huntington's disease

Tibrewal P, Bastiampillai T, Dhillon R, Cheng R, Fonseka HT.

Asian J Psychiatr. 2017 Apr;26:152-153. doi: 10.1016/j.ajp.2017.01.011. Epub 2017 Jan 19.

Hello from the Other Side: How Autoantibodies Circumvent the Blood-Brain Barrier in Autoimmune Encephalitis

Platt MP, Agalliu D, Cutforth T.

Front Immunol. 2017 Apr 21;8:442. doi: 10.3389/fimmu.2017.00442. eCollection 2017.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias